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Abstract (200 words or less) 23 
Globally, the eradication of bovine viral diarrhoea virus (BVDV) is still in its infancy 24 
but eradication has been, or is being, adopted by several countries or regions. 25 
Comparisons between countries’ schemes allow others to assess best practice, and 26 
aggregating published results from eradication schemes provides greater statistical 27 
power when analysing data. Aggregating data requires that results derived from 28 
different testing schemes be calibrated against one another. We aimed to evaluate 29 
whether relationships between published BVDV test results could be created and 30 
present the outcome of a systematic literature review following the Preferred 31 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 32 
The results are tabulated, providing a summary of papers where there is potential 33 
cross-calibration and a summary of the obstacles preventing such data-aggregation. 34 
Although differences in measuring BVDV present barriers to academic progress they 35 
may also affect progress within individual eradication schemes. We examined the 36 
time taken to retest following an initial antibody BVDV test in the Scottish eradication 37 
scheme. We demonstrate that retesting occurred quicker if the initial not negative 38 
test was from blood rather than milk samples. Such differences in the response of 39 
farmers/veterinarians to tests may be of interest to the design of future schemes.  40 
 41 
Word Count: 199  42 
 43 
  44 
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Introduction 45 
Programs designed to eradicate bovine viral diarrhoea virus (BVDV) appear, overall, 46 
to be making progress, and they exist in various countries (AHI 2014, AHWNI 2014, 47 
Barrett and others 2011, Graham and others 2014, Lindberg and others 2006, Presi 48 
and others 2011, Sandvik 2004). Other programs are also planned (Farmers Weekly 49 
2014, Laurens, 2014).  The variation in the design of these existing programs is of 50 
use in designing future programs because it allows comparison of different strategies 51 
and lessons to be learnt. The publication of results from different programs around 52 
the world also provides a potential opportunity for combining data or results to 53 
increase the statistical power when testing scientific hypotheses (Egli 2014). 54 
 55 
In Scotland, the eradication of BVDV is on its fourth stage (Scottish Government 56 
2014a). The majority of eradication programs attempt to split herds into ‘possibly 57 
infected’ and ‘uninfected’ (Lindberg and others 2006, Prezi and others 2011). In 58 
Scotland the two categories are labelled as ‘not negative’ and ‘negative’. Negative 59 
herds continue to be monitored in case their status changes. Not negative herds 60 
should initiate further testing, commonly trying to find persistently infected (PI) 61 
animals and have their movements restricted (Scottish Government 2014b).  62 
 63 
Within the Scottish BVDV eradication scheme there are eight possible testing 64 
methods (including three types of calf sampling) and eight groups of laboratories that 65 
can process the tests (Scottish Government 2015a, Scottish Government 2015b). 66 
Samples may be tissue, semen, blood or milk and can be tested for antigen or 67 
antibody (Scottish Government 2014c).  68 
 69 
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For dairy herds, bulk milk samples are common in eradication schemes to identify 70 
antibody status with antigen blood testing frequently used to establish whether the 71 
herd is currently infected and to find PI animals. For beef herds, blood testing 72 
predominates. The difference between common types of bulk milk and blood tests 73 
provides a useful example of the ramifications of differences in tests. 74 
 75 
Within each sampling method (as described above) there are also many different 76 
laboratory tests for BVDV (Lanyon and others 2014a) and a comprehensive list of 77 
those available is beyond the scope of this paper. Many of the tests available are 78 
based on detection of the virus or the antibody to the virus, and use enzyme-linked 79 
immunosorbent assay (ELISA), immunohistochemical tests, reverse transcription 80 
polymerase chain reaction (RT-PCR), or neutralization serum antibody tests 81 
(Radostits and others 2007). The variation in test regime depends upon a 82 
combination of the particular kit manufacturer, the sampling regime and the tissues 83 
sampled. 84 
 85 
Between eradication schemes, variety provides a series of “natural experiments” in 86 
which different schemes adopt different tests and, thus, the international community 87 
has evidence regarding their relative merits. However, this depends on how the tests 88 
and their results are reported, and people in business rarely have time to dwell on 89 
the complexities of test performance (e.g. sensitivity and specificity). The use of 90 
different tests is not only important to the researcher, but also to the farmer, 91 
veterinarian and the eradication scheme.   92 
 93 
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We set out to try to establish relationships between reported BVDV test results. The 94 
first step in this was a systematic literature review using the Preferred Reporting 95 
Items for Systematics Reviews and Meta-Analyses (PRISMA) guidelines (Moher and 96 
others 2009). We present the results of this review followed by a discussion of the 97 
difficulties we had in using the results to establish a relationship between tests. As a 98 
consequence of the difficulties we encountered, we also examined the test results 99 
from the Scottish BVDV eradication scheme to see if the industry treated results from 100 
blood and milk tests differently. We present the results of these tests and a 101 
discussion surrounding the differences between blood and milk tests. 102 
  103 
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Materials and Methods 104 
Systematic Review 105 
In order to find as many as possible, in a repeatable and documented way,  of the 106 
papers that have published results that would help us compare test results we 107 
conducted a systematic literature review using PRISMA guidelines (Moher and 108 
others 2009). Full details of our review process are shown below: 109 
1. An advanced search was made on Web of 110 
Science http://webofknowledge.com/ 111 
2. The search we used was: 112 
(TI= ((bovine viral diarr*) OR (BVDV) OR(bovine virus diarr*)) AND 
(TI=(milk OR antibod* OR *prevalence OR eradication OR herd OR elisa)))  
3. The results were initially filtered on web of science by selecting the document 113 
type, research domain and language. 114 
i. Document Types: Article or Review 115 
ii. Research Domain: Science Technology 116 
iii. Language: English 117 
4. The results were exported in tab delimited format to Windows including their 118 
abstracts (where possible). The remaining filtering took place in Microsoft 119 
Excel. 120 
5. The results which didn’t have an abstract exported (AB column) were 121 
removed.  122 
6. The results that stemmed from a conference (CT column) were removed.  123 
7. We then removed any results which we could not access electronically or 124 
were not available in paper format from previous work. Double entries were 125 
removed. 126 
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8. Papers were then submitted to two screening questions: 127 
i. Are numerical results, a statistical model or graphs produced from 128 
which the reported results can be read? 129 
ii. Are multiple tests or multiple testing procedures used? Failing that is 130 
there an equation that can be used to compare with other results? 131 
We retained only those publications where quantitative results (e.g. number of 132 
animals positive in herd, number of PI, test scores or percentages) were 133 
available for comparison from tables or graphs. The exception was where an 134 
equation or model governing the relationship between test results, test types 135 
or PI animals was reported. 136 
 137 
For each paper we extracted the following information into tabular form: the sample 138 
types (blood/bulk milk), the tests used, how the results are presented, whether 139 
individual PI animal status was reported, whether the animals/herds tests were 140 
vaccinated, and an explanation of why we think the result can or cannot be used to 141 
link to another paper/test. As the papers were subjectively assessed there is a risk of 142 
bias across the studies from step 8 above and in extracting the results from the 143 
publication. Where the lead author was in any doubt, one of the other authors acted 144 
as a secondary reviewer. 145 
 146 
Retesting Analysis of the Scottish BVDV Eradication Scheme 147 
To establish whether the results from blood and milk antibody tests are treated 148 
differently we used the results of the BVD eradication scheme in Scotland. Results 149 
were collated and matched by the County, Parish, Holding (CPH) unique identifier. 150 
For each CPH we identified the first blood or milk antibody test and then established 151 
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the number of days for the same CPH to conduct an antigen test. Those antigen 152 
tests taking place less than nine days after the antibody test were counted as part of 153 
the same testing due to the length of time needed to return test results to the CPH in 154 
question. These resampling results are presented as a proportion of those CPHs 155 
within each class of the same initial test (milk or blood) and initial test result 156 
(negative or not negative). Only the test results recorded as “Negative” or “Not 157 
Negative” were used. To use other values would have necessitated a subjective 158 
interpretation of the overall test result. 159 
 160 
To establish if there was a statistical significant difference in the proportions of 161 
holdings retesting within 90 days (AFBI 2015, DEFRA 2015) based on the type of 162 
initial antibody test, we carried out a two-sided proportion test and a survival 163 
analysis. We selected a 90 day threshold for our analyses because this is the period 164 
within which retesting is normally recommended or required for bulk milk tests, 165 
regardless of herd status (AFBI 2015, DEFRA 2015). The CPHs were split by initial 166 
test type (milk or blood). Those CPHs that did not retest within 90 days, regardless of 167 
whether they later retested, were treated as “not retesting”.  168 
 169 
For the proportion test (Newcombe 1998) a two by two table of counts (resample 170 
before 90 days yes/no versus initial antibody test blood/milk) was constructed before 171 
we used the prop.test function in the statistical software R (R Core Team 2015) to 172 
carry out the test. The survival analysis was carried out using the survival package 173 
(Therneau 2015, Therneau and Grambsch 2000).  174 
 175 
  176 
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Results 177 
Systematic Review 178 
Table 1 shows the papers that completed the PRISMA systematic review process. 179 
For each paper we show: the sample types (blood/bulk milk), tests used, result 180 
format, whether individual PI animal status was reported, the vaccination status of 181 
the animals/herds (if reported) and description of whether the result can be used to 182 
link to another paper/test. The number of papers that remained after each stage of 183 
our process described above are shown in table 2.  184 
 185 
The papers in table 1 should allow us to compare results from different tests and 186 
different testing methods. However, we encountered significant difficulties in doing 187 
so. The most common difficulties surrounded vaccination and test variety.  188 
 189 
Retesting Analysis of the Scottish BVDV Eradication Scheme 190 
Figure 1 shows the proportion of farms (in the Scottish BVDV eradication scheme 191 
2013-2014) retesting over the year, split by the type of initial test. (Red, solid: initial 192 
negative blood test. Green, short dashed: initial not-negative blood test. Blue, 193 
dashed: initial negative milk test. Purple, long-dashed: initial not-negative milk test.)  194 
There is a clear difference between the time taken to retest. Within the first 90 days, 195 
farms are more likely (p = 0.05139 from the two-sided test of proportions) to retest 196 
following a not-negative result if the initial test was using blood testing rather than 197 
bulk milk. This is confirmed by the survival analysis which provides a relative risk of 198 
0.73 with a 95% confidence interval of (0.54, 0.98) and a rejection of the null 199 
hypothesis that the relative risk is one, based on a p-value of 0.037. 200 
 201 
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Discussion 202 
Whilst progress appears to be being made in the uptake of eradication schemes for 203 
BVDV around the world, it is still in its infancy, with more countries not yet planning 204 
such a scheme than there are countries planning, in the process of, or having 205 
achieved, eradication (Moennig and Becher 2015). We are therefore at a useful 206 
stage in the global eradication trend, because we can make use of data being 207 
reported from the different schemes from around the world. Results from schemes 208 
can be used either by aggregating data in order to achieve increased statistical 209 
power when asking epidemiological questions (e.g. does herd size affect the 210 
probability of a herd containing a PI and by how much?) or, qualitatively, by heeding 211 
the lessons learnt from the reports of successful and unsuccessful strategies. Here 212 
we describe the difficulties we had in aggregating data and present evidence from 213 
one particular scheme in which the differences in farmers’/veterinarians’ perception 214 
of the test may be influencing the time taken to retest. Comparative studies of 215 
strategies within a scheme may be even more powerful than between schemes 216 
because unknown confounders (at the scheme level) should be effectively controlled 217 
for. 218 
 219 
Aggregating data requires that data be “calibrated” into common and genuinely 220 
equivalent units (e.g. within herd seroprevalence) and therefore is dependent on 221 
comparing results from different schemes with different methods. The difficulties 222 
encountered in comparing results from different papers were mainly due to: 223 
vaccination, the variety of tests used and how their results were reported. It is clear 224 
from table 1 that some papers have vaccinated animals whilst other are 225 
unvaccinated or vaccination status is not reported.  Some eradication schemes have 226 
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banned vaccination (Lindberg and others 2006) and comparing antibody results 227 
across studies without accounting for differences in vaccination regimes risks 228 
ignoring vaccination as a clear confounder (Bauermann and others 2013, Gonzalez 229 
and others 2014a, 2014b, Humphry and others 2012, Stevens and others 2011).  230 
 231 
Whilst vaccine usage might possibly be dictated by an eradication scheme, 232 
(Lindberg and others 2006) the particular laboratory tests used could be more 233 
difficult to control. For example, within the Scottish BVDV eradication scheme the 234 
testing methods and the laboratories analysing them are controlled but not the 235 
manufacturer of the tests they use (Scottish Government 2015a). Table 1 gives  an 236 
example of the variety of tests for both blood and milk that are reported in the 237 
literature. Tests range from those used by specific laboratories to bespoke (Houe 238 
1994, Houe and Meyling 1991, Rüfenacht and others 2000). Some results are 239 
reported with insufficient detail to allow comparison. For example, the percentage 240 
inhibition results from Booth and others (2013) are reported without the control 241 
values needed to replicate them.  However, in Niskanen and others (1991) and 242 
Niskanen (1993), the control values are reported. Incomplete reporting of results 243 
may not be the authors’ choice - it may arise from the laboratory or test used. 244 
However, where full details can be made available, doing so would assist other 245 
researchers and, possibly, those in charge of eradication schemes. 246 
 247 
The accuracy and reliability of the type of test should also be considered as this can 248 
be used to estimate confidence ranges around any calibrated result from one 249 
scheme in comparison to another. For example there is good evidence (Brülisauer 250 
and others 2010, Humphry and others 2012) that using the proportion of seropositive 251 
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young-stock gives better classification of herds into  distinct antibody-level groups 252 
than bulk milk antibody scores. Figure 2 shows the frequency distribution for 253 
percentage positivity (PP) scores of bulk milk tests for 220 Scottish farms whilst 254 
figure 3 shows the frequency of 10 young stock that were BVDV seropositive in 274 255 
Scottish herds. Even with the complicating observation of a small spike at about 5 256 
seropositive animals in figure 2 (see Brülisauer and others (2010) for a full 257 
discussion) the bloods have a very clear second maximum for 9 and 10 seropositive 258 
animals, whereas the bulk milk results have no clear separation.  259 
 260 
This suggests that at herd-level, bulk milk results are more likely to produce false 261 
positives, or false negatives than is the serum screening of young-stock. Bulk milk 262 
antibody scores are not only an average of contributing animals but they also 263 
represent an average over time, reflecting historic as well as current BVDV status. 264 
The removal of PI animals will not necessarily produce an immediate change in bulk 265 
milk results (figure 4 - reproduced from Houe 1999). It is clear that even three years 266 
after the removal of the final PI animal, the bulk milk results had not changed greatly.  267 
 268 
Differences in the “performance” of a test are not just of importance to academic 269 
researchers when trying to make use of reported results from around the world. 270 
These differences, whilst appearing highly epidemiological and quantitatively 271 
technical, are also of great importance to the individual scheme itself and to the 272 
farmers and practitioners within the scheme. How farmers and their veterinarians 273 
respond to any difference in test performance (sensitivity and specificity) is hard to 274 
predict. A precautionary approach may be adopted – i.e. any bulk milk score which is 275 
just negative might be followed up with additional tests lest it be a false negative. 276 
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Conversely, a riskier approach might be that any not-negative test be considered a 277 
probable false positive. The Scottish Eradication data provides evidence that may 278 
be, in part, an example of scheme members responding to different tests according 279 
to the different test performance. 280 
 281 
Figure 1 shows that the length of time taken to retest from an initial not negative 282 
antibody test result is dependent on whether that initial test was a blood or a milk 283 
test. It is possible that farmers take a not-negative result from blood more seriously 284 
and hence retest quicker. Farmers may be taking the riskier approach with the not 285 
negative milk result which we suggested above. We should also consider whether 286 
dairy farms treat PI calves with less concern than beef farms as calves are removed 287 
from dairy herds at a younger age than in beef herds. Other explanations include the 288 
availability of follow up tests depending on whether the farm is beef or dairy, if the 289 
financial impact of a movement ban of animals is greater for beef farms or if there is 290 
more pressure within the beef sector for retesting.  291 
 292 
We do not know why those receiving not negative blood test results retest quicker 293 
but the discussion about bulk milk results is pertinent not least because the Scottish 294 
Government have removed the option for bulk milk tests from June 1st, 2015 295 
(Scottish Government 2015c). This seems understandable as eradication enters its 296 
next phase, given the importance of successful detection of the virus and the relative 297 
imperfection of the bulk milk antibody test but this policy differs from some other 298 
schemes (Hult and Lindberg 2005).  299 
 300 
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Whilst we have acknowledged the limitations of bulk milk testing, this is not to 301 
dismiss the value of testing milk from all or some cows in a herd. Milk sampling from 302 
a sub-group of milking animals can be particularly useful for testing new heifers 303 
whose antibodies provide a “signal” of recent rather than historic infection (Brownlie 304 
and Booth 2014, Houe and others 2006, Ohlson and others 2013). It is therefore 305 
reasonable that, after a scheme has effectively eradicated BVDV (and depending on 306 
vaccination regimes), the relatively convenient and cheap test that is bulk milk 307 
testing may come into its own as a first line of screening for sporadic breakdown 308 
(Booth and others 2013). 309 
 310 
There are many different tests available for BVDV and a lot of research has been 311 
published detailing test results and progress in eradication schemes (Laurens 2014, 312 
Lindberg and others 2006, Sandvik 2004). Whilst not of immediate concern to the 313 
design of a scheme, taking into account how transferable the results of that scheme 314 
are with data from other schemes has the added benefit of facilitating research 315 
based on aggregating results. When designing an eradication scheme the testing 316 
methods and individual tests available should be considered to ensure that a variety 317 
of tests within the scheme does not discombobulate the scheme itself. If the scheme 318 
is too complicated, this will only hinder the eradication.    319 
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Table 1: Details of the papers from the PRISMA systematic review. The table shows the bulk milk and 615 
blood tests used, the results format, whether or not the PI status of individual animals was reported, 616 
whether the herds/animals tested were vaccinated or not and if the authors think it possible to link the 617 
results to another test or paper. (Abbreviations other than company names, not used previously: Ab – 618 
antibody, Ag – antigen, IPMA – immunoperoxidase monolayer assay, OD – optical density, PP – 619 
percentage positive, VNT – virus neutralisation test, VI – virus isolation)  620 
 621 
Paper Bulk Milk (Test) Bloods (Test) Results reported as: 
PI status 
reported 
Vaccinated / 
Unvaccinated 
Is link to another paper 
possible? 
Ahmad and 
others 2014 No 
Yes – (Herdcheck 
IDEXX Antigen 
Capture Elisa 
tested against 
immunochemisitry 
and RT-PCR) 
Comparison of 
positive results 
across tests  
No No mention of vaccination. 
Difficult to link as no sample 
values given for the sample to 
positive ratio 
Beaudeau and 
others 2001a 
Yes – (LSI 
BVD/BD p80 
blocking ELISA) 
No 
Equation relating 
herd prevalence to 
percentage inhibition 
No 
82 of 112 used 
in equation no 
history 
vaccinated 
No control values reported and 
percentage inhibition defined 
by OD control 
Beaudeau and 
others 2001b  
Yes – (Pourquier 
BVD/MD p80 
milk ELISA) 
Yes – (VNT on 
matched sera) 
Comparison of OD 
(%) from ELISA and 
the VNT titre.  
 
Plot of OD (%) vs 
within-herd 
prevalence of 
positive animals. 
No Nothing reported. 
As with previous paper, cannot 
read the percentages off the 
graphs and no equation given 
for relationship between OD 
and within-herd prevalence 
(unlike first Beadeau paper). 
Beaudeau and 
others 2001c 
Yes – (LSI 
BVD/DB p80 
blocking ELISA) 
Yes – (VNT and 
LSI BVD/BD p80 
blocking ELISA) 
Comparison of 
percentage inhibition 
from ELISA of serum 
vs VNT titre of same 
sample. 
 
Comparison of 
percentage inhibition 
from ELISA of bulk 
milk and VNT of 
matched serum. 
No 
No specific 
reporting of 
number of 
vaccinated 
herds. Makes 
point that “cut-
off values 
provided by 
the ROC 
analysis were 
insensitive” to 
vaccination. 
So many results that can’t read 
the percentage inhibition from 
graphs for the fixed titres. 
Provides cut off of 50% 
inhibition as +/-. 
Booth and 
others 2013 
(using Booth 
and Brownlie  
2011 for 
additional 
information) 
Yes – (AHVLA 
indirect ELISA – 
claimed to be 
”broadly 
comparable” to 
SVANOVA 
indirect ELISA) 
Yes – (Antigen 
ELISA if 
>6months, pooled 
PCR if <6months) 
OD ratio, PIs, 
percentage BM 
contributors’ 
positive, negative. 
Yes  
Two farms that 
didn’t 
vaccinate. 
No control values given, no 
precise calculation. Sensitivity 
and Specificity given in Booth 
and others 2011 approximate. 
Bosco Cowley 
and others 2012 
Yes – (Svanova 
ELISA-Ab) 
Yes – (Svanova 
ELISA-Ab on 
pooled samples) 
Only contingency 
table for relationship 
between blood and 
milk results.  
 
PP from pooled 
serum vs % of 
positive samples 
plotted. Polynomial 
relationship. 
No 
All analysis 
applied to 
unvaccinated 
herds 
Polynomial relationship 
between PP and % positive 
samples not published. Need 
full results rather than 
contingency table. 
Cornish and 
others 2005 No 
Yes – (Syracuse 
Bioanalytical Inc. 
Ag ELISA with VI 
and RT-PCR to 
confirm) 
Table of PI animals 
with results from VI, 
RT-PCR and ELISA 
with VN titre.  
Yes 
All dams of 
calves tested 
were 
vaccinated. 
Could compare with similar 
tests on calves. 
Diéguez and 
others 2008 
Yes – (Pourquier 
BVD/MD p80 
blocking ELISA) 
Yes – (Pourquier 
BVD/MD p80 
blocking ELISA &  
IDEXX ELISA 
antigen serum 
plus BVD test kit) 
Plot of herd 
seroprevalence vs 
% inhibition in BTM.  
Tested for 
but results 
not 
tabulated 
or plotted. 
Yes 
No explicit results given, just 
cut-offs. Could compare with 
other papers using the same 
tests if we could get the 
complete results. 
Eiras and 
others 2012 
Yes – (Pourquier 
BVD/MD/BD 
p80, Civtest 
bovis BVC p80, 
IDEXX 
HerdChek 
Yes – (Pourquier 
BVD/MD/BD p80 
& IDEXX antigen 
serum kit) 
Threshold of 
transformed optical 
density values of all 
four bulk milk tests 
compared against 
thresholds 
No 
24% of herds 
have been 
vaccinated 
78/325. 
No control values given and 
some herds vaccinated. If all 
sample results provided then a 
relationship between the tests 
might be established. 
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BVDV, 
SVANOVA 
Svanovir BVDV-
Ab) 
established from 
blood tests. 
Foddai and 
others 2015 
Yes – (Danish 
blocking ELISA 
(Bitsch and 
others 1997) &  
SVANOVA 
BVDV-Ab 
ELISA)  
Yes – (Danish 
blocking ELISA 
(Bitsch and others 
1997) &  
SVANOVA BVDV-
Ab ELISA) 
Graphs of PP vs 
blocking % for both 
milks and bloods. 
No No mention of vaccination. 
Could compare to others using 
the same test. Numbers little 
difficult to read accurately from 
plots.  
Graham and 
others 2003 
Yes – 
(SVANOVA 
indirect BVDV-
Ab ELISA & LSI 
blocking ELISA 
NS2-3) 
Yes – (SVANOVA 
indirect BVDV-Ab 
ELISA & LSI 
blocking ELISA 
NS2-3 & VNT 
described in 
Graham and 
others 1997) 
Mean results of tests 
from groups before 
and after 
vaccination. 
 
Plots (with best fit 
lines) of Indirect 
ELISA COD against 
VN titre and % 
inhibition of blocking 
ELISA 
No 
All animals 
vaccinated 
during testing 
If the lines of best had been 
published they could be used 
to compare the results of 
Indirect ELISA COD with either 
VN titre or blocking ELISA – if 
other animals have used the 
same vaccines. 
Hanon and 
others 2014 No 
Yes – 
(ADIAGENE, 
Adiavet BVDv 
RRT-PCR test & 
IDEXX BVDV 
Ag/serum plus 
ELISA) 
Predicted probability 
of PI animal based 
on the Ct value from 
the RRT-PCR. 
Yes No mention of vaccination. 
If the equation or similar for the 
model had been reported then 
could find the probability of PI 
from any other study using the 
same test. 
Houe 1994 Yes – (Indirect ELISA) 
Yes – (Meyling’s 
own test) 
Virus positive ~ ab 
positive ~ antibody 
titer in BM (related to 
OD) 
Yes Unvaccinated 
There are no explicit details 
provided on the indirect ELISA 
used but could link with Houe 
and Meyling 1991 as it too 
uses Meyling’s test. 
Houe and 
others 1995 No 
Yes – (IPMA 
(Meyling 1984) & 
VNT  
Tabulated values % 
of antibody positive 
vs mean/median 
antibody titer results. 
Yes 
Mixture of 
vaccination 
history. 
Could relate to other herds 
using those tests with the 
same vaccination history. 
Humphry and 
others 2012 
Yes – 
(SVANOVA 
indirect ELISA 
(percentage 
positive), the 
test from Drew 
and others 1999 
and SVANOVA 
indirect ELISA 
(corrected OD)) 
No 
percentage positive 
OD 
Corrected OD 
 
All linked to Swedish 
classes 
No Unvaccinated Could possibly link this to other papers using the same tests. 
Kuta and others 
2013 
Yes – 
(SVANOVA 
BVDV-Ab ELISA 
and SVANOVA 
BVDV-Ab ELISA 
confirmation 
format) 
No 
Correlation of COD 
values from initial 
ELISA and PP 
values from 
confirmatory ELISA 
for 28 herds that 
were double tested. 
Yes Unvaccinated 
Could be used to compare 
COD with PP from SVANOVA 
ELISA tests – providing the 
confirmation test is essentially 
the same as original. 
Lanyon and 
others 2013 No 
Yes – (IDEXX 
BVDV Total Ab 
and VNT Titre 
Regression equation 
linking VNT titre 
result and sample to 
positive ratio of 
ELISA 
No Unvaccinated 
Could be used to compare 
other VNT Titre results and 
ELISA results using the same 
test. 
Lanyon and 
others 2014b 
Yes – (IDEXX 
BVDV Total Ab 
Test) 
Yes – (IDEXX 
BVDV Total Ab 
Test and RT-PCR) 
Percentage of herds 
testing positive / 
negative  for both 
blood and milk tests. 
Relationship 
between milk and 
blood sample to 
positive ratios also 
presented.  
No No mention of vaccination 
Relationship of bulk milk to 
serum results could provide 
link if the same test has been 
used. 
Muvavarirwa 
and others 1995 No 
Yes – (ELISA (as 
described by 
Howard and 
others 1985) & 
serum 
neutralisation test) 
Comparison of 
results from ELISA 
and values of SN 
titre 
No No mention of vaccination 
Could compare with results 
from the same test or with SN 
titre.  
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Niskanen 1993 
Yes – 
(SVANOVA 
indirect ELISA) 
Yes – (SVANOVA 
indirect ELISA) 
Absorbance value ~ 
percentage prev of 
ab positive lactating 
cows in herds. 
No Unvaccinated 
Should link to any other 
SVANOVA indirect ELISA 
(control values given) 
Niskanen and 
others 1991 
Yes – 
(SVANOVA 
indirect ELISA) 
Yes – (SVANOVA 
indirect ELISA) 
# ab positive ~ 
absorbance values 
of bulk milk. 
PIs were 
removed Unvaccinated 
Should link to any other 
SVANOVA indirect ELISA 
(control values given). PIs 
removed in between two of the 
yearly results. 
Rüfenacht and 
others 2000 
Yes – (Authors’ 
own ELISA) 
Yes – (Antigen 
capture ELISA 
(Strasser) and RT-
PCR (Wirz)) 
Herd abpositive 
prevalence ~ 
Antigen ELISA 
positive (1st and 2nd 
tests) /ab ELISA 
positive /RT-PCR 
positive 
Yes Unvaccinated 
Test is author created so very 
difficult to link to a more widely 
used test. 
Sandvik  and 
Krogsrud 1995 No 
Yes – (SVANOVA 
ELISA ab test, 
Moredun antigen 
test) 
Tabulated values of 
antibody OD vs 
antigen OD. 
No Unvaccinated 
Could possibly be used to 
create link between SVANOVA 
test and antigen results. 
Schreiber and 
others 1999 No 
Yes – (Specific 
test unclear) 
Table of number of 
animals in herd with 
number of 
seropositive and PI 
per herd 
Yes 
37% 
vaccinated but 
type of 
vaccine 
produces few 
to none 
antibodies 
Can link between other herds 
with PI animals although 
specific test used unclear. 
Ståhl  and 
others 2008 
Yes- (SVANOVA 
indirect ab 
ELISA) 
Yes – (IDEXX 
BVDVB 
Ag/Serum) 
Table of number of 
positive spot blood 
tests and mean OD 
for the bulk milk 
tank. 
Yes 
7 out of 55 
herds 
vaccinated 
Could create link between bulk 
milk and number of positive 
young stock if same tests 
used. 
Taylor and 
others 1995 No 
Yes – (Bespoke 
Ab ELISA with 
VNT and PCR) 
Table of each pen 
with titre, ELISA, VN 
and PCR results 
with number of 
animals tested per 
pen. 
Yes 
No specific 
mention of 
vaccination for 
BVDV. 
Difficult to compare as the 
ELISA created was bespoke. 
Vanderheijden 
and others 1993 No 
Yes – (Would 
appear to be 
bespoke p80 
ELISA test & SN) 
Table comparing SN 
titre vs p80 results. Yes 
2 tests 
specifically 
designated as 
vaccinated or 
unvaccinated. 
Could compare with other 
results from same test. 
Weir and others 
2013 
Yes – (IDEXX 
ELISA) 
Yes – (IDEXX 
ELISA) 
Plot of milk S/P ratio 
vs serum S/P ratio 
with regression line. 
No Unvaccinated 
Could be used to compare 
results from previous tests if 
regression line had been 
provided. 
Zimmer and 
others 2002 
Yes – (Ceditest 
BVD blocking 
ELISA) 
Yes – (Ceditest 
BVD blocking 
ELISA) 
Proportion of herd 
ab+ vs status of 
herd from btm 
Yes No mention of vaccination. 
Could be used to compare with 
btm results using the same 
test. 
Zimmer and 
others 2004 No 
Yes – (Antibody 
test via VNT, 
Antigen test via VI, 
Synbiotics ELISA 
and RT-PCR 
Table showing 
results for each calf 
tested – titre vs 
antigen test and RT-
PCR and serological 
titre. 
Yes No mention of vaccination 
Useful comparison with other 
studies on calves and using 
the same tests. 
 622 
 623 
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Table 2: The number of papers still available to the authors after each step of the PRISMA 625 
systematics review 626 
Step  of 
PRISMA 
1- 
Web of 
Science 
2 - 
Search 
Terms 
3 - 
Filter 
Results 
5 - 
Remove 
No 
Abstract 
6 - 
Remove 
Conference 
Papers 
7 - 
Collect 
Papers 
8 - 
Screening  
Questions 
Number of 
Papers remaining 
following that step 
> 109 654 508 386 352 259 
28 electronic 
and 2 non-
electronic.  
  627 
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Figure 1: Time taken (days) from an initial antibody test to retesting for antigen, separated by 628 
initial antibody test type (milk and blood) and result (negative/not-negative). (Red, solid: initial 629 
negative blood test. Green, dotted: initial not-negative blood test. Blue, dashed: initial negative 630 
milk test. Purple, long-dashed: initial not-negative milk test.) Data is taken from the Scottish 631 
BVDV eradication scheme 2013 – 2014. 632 
 633 
Figure 2: Frequency distribution of percentage positivity results from 220 BVDV bulk milk tests 634 
from a survey of 220 Scottish Farms. Previously published in Humphry and others 2012. 635 
 636 
Figure 3: Number of seropositive animals from 10 young stock sampled in a survey of 274 637 
Scottish herds. Previously published in Brülisauer and others 2010.   638 
 639 
Figure 4: Plot of the blocking percentage of antibody reaction in a bulk milk tank against days 640 
after the removal of the last persistently infected animal. A Linear regression line is also shown. 641 
Reproduced with permission from Houe 1999.  642 
 643 
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